This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liaw, Y. S. Articles by Luh, K. T. Search for Related Content PubMed PubMed Citation Articles by Liaw, Y. S. Articles by Luh, K. T.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 06 1995, 1588-1591, Vol 33, No. 6
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Direct determination of cryptococcal antigen in transthoracic needle aspirate for diagnosis of pulmonary cryptococcosis

YS Liaw, PC Yang, CJ Yu, DB Chang, HJ Wang, LN Lee, SH Kuo and KT Luh
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Republic of China.

Pulmonary cryptococcosis causes significant morbidity and mortality in immunocompromised patients. Definitive diagnosis of pulmonary cryptococcosis is usually difficult. The use of direct determination of cryptococcal antigen in transthoracic needle aspirate to diagnose pulmonary cryptococcosis was investigated. Over a 2-year period, we studied a total of 41 patients with respiratory symptoms and pulmonary infiltrates of unknown etiology who were suspected of having pulmonary cryptococcosis. Twenty-two patients were immunocompetent patients and 19 patients were immunocompromised. A diagnosis of pulmonary cryptococcosis was based on cytological examination, culture for Cryptococcus neoformans, histopathologic examination, and clinical response to antifungal therapy. All patients underwent chest ultrasound and ultrasound-guided percutaneous transthoracic needle aspiration to obtain specimens for cryptococcal antigen determination. The presence of cryptococcal antigen was determined by the latex agglutination system (CALAS; Meridian Diagnostics, Cincinnati, Ohio). An antigen titer equal to or greater than 1:8 was considered positive. The specimens were also sent for cytological examination, fungal culture, and/or histopathologic examination. A final diagnosis of pulmonary cryptococcosis was made in eight patients. Direct determinations of cryptococcal antigen in lung aspirate were positive in all eight patients with pulmonary cryptococcosis (100% sensitivity, 97% specificity, a positive predictive value of 89%, and negative value of 100%), and there was only one false-positive in noncryptococcosis patients. The diagnostic accuracy was 97.5%. Serum cryptococcal antigen was positive in only three patients with pulmonary cryptococcosis (sensitivity, 37.5%). This study showed that direct measurement of cryptococcal antigen in lung aspirate can be a rapid and useful test for diagnosis of pulmonary cryptococcosis.

This article has been cited by other articles:

• Chen, K.-Y., Ko, S.-C., Hsueh, P.-R., Luh, K.-T., Yang, P.-C. (2001). Pulmonary Fungal Infection : Emphasis on Microbiological Spectra, Patient Outcome, and Prognostic Factors. Chest 120: 177-184 [Abstract] [Full Text]  
• Nunez, M., Peacock, J. E. Jr, Chin, R. Jr (2000). Pulmonary Cryptococcosis in the Immunocompetent Host : Therapy With Oral Fluconazole: A Report of Four Cases and a Review of the Literature. Chest 118: 527-534 [Abstract] [Full Text]  
• Scott, J. A. G., Hall, A. J. (1999). The Value and Complications of Percutaneous Transthoracic Lung Aspiration for the Etiologic Diagnosis of Community-Acquired Pneumonia*. Chest 116: 1716-1732 [Full Text]  
• Kralovic, S. M., Rhodes, J. C. (1998). Utility of Routine Testing of Bronchoalveolar Lavage Fluid for Cryptococcal Antigen. J. Clin. Microbiol. 36: 3088-3089 [Abstract] [Full Text]